Inhaled insulin, taken before meals, can improve blood glucose control for people with type 2 diabetes who have not had good results with short-acting injected insulin that is taken in addition to the baseline insulin administered throughout the day and night, according to a new review of the body of published research.
As the massive Baby Boomer generation braces for retirement, many are turning to long-term care insurance to prepare for potential age-related care.
A new study by the United Nations refugee agency disputes assumptions that violence and rape propel the HIV epidemic in conflict areas, with those forced to flee having a high prevalence of the virus.
The World Health Organization (WHO) released results from a research project warning that the risk of developing fatal blood clots during travel doubles after the passenger has been seated for four hours or more.
Indian President A P J Abdul Kalam asked the Indian companies to tap the vast potential for health care products in the international market by maintaining competitive pricing and high quality.
At the thought of addressing a classroom or alarger auditorium packed to its capacity some people break out into a sweat, their legs turn to jelly, and their hearts begin to pound wildly or go light-headed.
Health Canada is warning consumers not to use the product Encore Tabs for Men, because it contains an undeclared pharmaceutical ingredient similar to the approved drug tadalafil.
The drug most commonly used to arrest preterm labor, magnesium sulfate, is more likely than another common treatment to cause mild to serious side effects in pregnant women, according to a study from researchers at Lucile Packard Children’s Hospital and Stanford University School of Medicine.
In May, Nobel Laureate James D. Watson, the scientist who co-discovered the structure of DNA, became the first person to receive his own complete personal genome — all three billion base pairs of his DNA code sequenced. The cost was $1 million, and the process took two months.
Ovarian germ cell tumor patients treated with platinum-based chemotherapy and fertility-sparing surgery are likely to retain their menstrual function and reproductive ability, according to the largest and most comprehensive survey of survivors ever conducted.